WallStreetZenWallStreetZen

Sectors & IndustriesHealthcareDrug Manufacturers - Specialty & Generic
Best Pharmaceutical Stocks to Buy Now (2024)
Top pharmaceutical stocks in 2024 ranked by overall Zen Score. See the best pharmaceutical stocks to buy now, according to analyst forecasts for the drug manufacturers - specialty & generic industry.

Industry: Drug Manufacturers - Spec...
Ticker
Company
Dividends Score
Market Cap
Dividend Yield
Payout Ratio
Last Dividend
Annual Dividend
Dividend Percentile
Dividend Dropped Count (L10Y)
Ex-dividend Date
Div. Payment Date
NBIX
NEUROCRINE BIOSCIENCES INC
$13.72BN/A0.00%N/AN/AN/AN/A
KMDA
KAMADA LTD
$321.89MN/A0.00%N/AN/AN/AN/A
AMPH
AMPHASTAR PHARMACEUTICALS INC
$2.09BN/A0.00%N/AN/AN/AN/A
PCRX
PACIRA BIOSCIENCES INC
$1.35BN/A0.00%N/AN/AN/AN/A
LNTH
LANTHEUS HOLDINGS INC
$4.14BN/A0.00%N/AN/AN/AN/A
HCM
HUTCHMED (CHINA) LTD
$2.94BN/A0.00%N/AN/AN/AN/A
SIGA
SIGA TECHNOLOGIES INC
$604.28M12.35%47.40%$0.6000$1.0596%02024-04-11
SCYX
SCYNEXIS INC
$53.02MN/A0.00%N/AN/AN/AN/A
COLL
COLLEGIUM PHARMACEUTICAL INC
$1.31BN/A0.00%N/AN/AN/AN/A
ZTS
ZOETIS INC
$77.16B0.92%30.60%$0.4320$1.5617%02024-04-182024-06-04
TXMD
THERAPEUTICSMD INC
$23.79MN/A0.00%N/AN/AN/AN/A
ANIP
ANI PHARMACEUTICALS INC
$1.47BN/A0.00%N/AN/AN/AN/A
ALKS
ALKERMES PLC
$4.55B3.93%50.00%$1.0700$1.0768%0
PAHC
PHIBRO ANIMAL HEALTH CORP
$528.98M3.68%129.70%$0.1200$0.4865%0
SUPN
SUPERNUS PHARMACEUTICALS INC
$1.85BN/A0.00%N/AN/AN/AN/A
TLRY
TILRAY BRANDS INC
$1.84BN/A0.00%N/AN/AN/AN/A
CRON
CRONOS GROUP INC
$1.03BN/A0.00%N/AN/AN/AN/A
RDY
DR REDDYS LABORATORIES LTD
$12.04B1.35%N/A$0.4877$0.9828%0
VTRS
VIATRIS INC
$14.05B2.03%960.00%$0.1200$0.2441%0
HLN
HALEON PLC
$39.39B0.54%15.90%$0.0460$0.059%02024-05-16
EOLS
EVOLUS INC
$811.21MN/A0.00%N/AN/AN/AN/A
ITCI
INTRA-CELLULAR THERAPIES INC
$6.75BN/A0.00%N/AN/AN/AN/A
ZOM
ZOMEDICA CORP
$141.11MN/A0.00%N/AN/AN/AN/A
FTLF
FITLIFE BRANDS INC
$109.23MN/A0.00%N/AN/AN/AN/A
DCPH
DECIPHERA PHARMACEUTICALS INC
$1.23BN/A0.00%N/AN/AN/AN/A
PROC
PROCAPS GROUP SA
$313.65MN/A0.00%N/AN/AN/AN/A
ETON
ETON PHARMACEUTICALS INC
$97.61MN/A0.00%N/AN/AN/AN/A
SCTL
SOCIETAL CDMO INC
$115.20MN/A0.00%N/AN/AN/AN/A
EGRX
EAGLE PHARMACEUTICALS INC
$65.06MN/A0.00%N/AN/AN/AN/A
SBFM
SUNSHINE BIOPHARMA INC
$1.46MN/A0.00%N/AN/AN/AN/A
CLVR
CLEVER LEAVES HOLDINGS INC
$8.55MN/A0.00%N/AN/AN/AN/A
TARO
TARO PHARMACEUTICAL INDUSTRIES LTD
$1.59BN/A0.00%N/AN/AN/AN/A
AQST
AQUESTIVE THERAPEUTICS INC
$300.53MN/A0.00%N/AN/AN/AN/A
OPTN
OPTINOSE INC
$166.72MN/A0.00%N/AN/AN/AN/A
DVAX
DYNAVAX TECHNOLOGIES CORP
$1.62BN/A0.00%N/AN/AN/AN/A
TLPH
TALPHERA INC
$18.67MN/A0.00%N/AN/AN/AN/A
PRGO
PERRIGO CO PLC
$4.26B3.48%-1,213.30%$0.2760$1.1062%0
QLI
QILIAN INTERNATIONAL HOLDING GROUP LTD
$21.81MN/A-22.70%N/AN/AN/AN/A
GHSI
GUARDION HEALTH SCIENCES INC
$11.49MN/A0.00%N/AN/AN/AN/A
ACB
AURORA CANNABIS INC
$226.05MN/A0.00%N/AN/AN/AN/A
TKNO
ALPHA TEKNOVA INC
$100.43MN/A0.00%N/AN/AN/AN/A
ORGO
ORGANOGENESIS HOLDINGS INC
$364.22MN/A0.00%N/AN/AN/AN/A
SXTC
CHINA SXT PHARMACEUTICALS INC
$768.37kN/A0.00%N/AN/AN/AN/A
RDHL
REDHILL BIOPHARMA LTD
$1.96MN/A0.00%N/AN/AN/AN/A
RMTI
ROCKWELL MEDICAL INC
$48.11MN/A0.00%N/AN/AN/AN/A
YCBD
CBDMD INC
$3.08MN/A0.00%N/AN/AN/AN/A
AYTU
AYTU BIOPHARMA INC
$17.15MN/A0.00%N/AN/AN/AN/A
ESPR
ESPERION THERAPEUTICS INC
$484.84MN/A0.00%N/AN/AN/AN/A
BFRI
BIOFRONTERA INC
$5.85MN/A0.00%N/AN/AN/AN/A
PRFX
PAINREFORM LTD
$3.08MN/A0.00%N/AN/AN/AN/A
EVOK
EVOKE PHARMA INC
$4.98MN/A0.00%N/AN/AN/AN/A
UPC
UNIVERSE PHARMACEUTICALS INC
$7.04MN/A0.00%N/AN/AN/AN/A
PTPI
PETROS PHARMACEUTICALS INC
$3.19MN/A0.00%N/AN/AN/AN/A
ASRT
ASSERTIO HOLDINGS INC
$94.05MN/A0.00%N/AN/AN/AN/A
ACOR
ACORDA THERAPEUTICS INC
$14.79MN/A0.00%N/AN/AN/AN/A
AVDL
AVADEL PHARMACEUTICALS PLC
$1.53BN/A0.00%N/AN/AN/AN/A
HROW
HARROW INC
$450.17MN/A0.00%N/AN/AN/AN/A
CPHI
CHINA PHARMA HOLDINGS INC
$2.80MN/A0.00%N/AN/AN/AN/A
DRRX
DURECT CORP
$39.97MN/A0.00%N/AN/AN/AN/A
CRDL
CARDIOL THERAPEUTICS INC
$116.64MN/A0.00%N/AN/AN/AN/A
KALA
KALA BIO INC
$21.14MN/A0.00%N/AN/AN/AN/A
INCR
INTERCURE LTD
$115.30MN/AN/AN/AN/AN/AN/A
FLGC
FLORA GROWTH CORP
$18.31MN/A0.00%N/AN/AN/AN/A
COSM
COSMOS HEALTH INC
$9.52MN/A0.00%N/AN/AN/AN/A
TAK
TAKEDA PHARMACEUTICAL CO LTD
$44.53BN/A0.00%$0.4064N/AN/A2
INDV
INDIVIOR PLC
$2.92BN/A0.00%N/AN/AN/AN/A
CGC
CANOPY GROWTH CORP
$870.14MN/A0.00%N/AN/AN/AN/A
DERM
JOURNEY MEDICAL CORP
$72.00MN/A0.00%N/AN/AN/AN/A
PETQ
PETIQ INC
$513.28MN/A0.00%N/AN/AN/AN/A
AKAN
AKANDA CORP
$664.83kN/A0.00%N/AN/AN/AN/A
LFCR
LIFECORE BIOMEDICAL INC
$157.93MN/A0.00%N/AN/AN/AN/A
RGC
REGENCELL BIOSCIENCE HOLDINGS LTD
$45.15MN/A0.00%N/AN/AN/AN/A
OGI
ORGANIGRAM HOLDINGS INC
$186.27MN/AN/AN/AN/AN/AN/A
CPIX
CUMBERLAND PHARMACEUTICALS INC
$25.38MN/A0.00%N/AN/AN/AN/A
EBS
EMERGENT BIOSOLUTIONS INC
$135.21MN/A0.00%N/AN/AN/AN/A
IRWD
IRONWOOD PHARMACEUTICALS INC
$1.35BN/A0.00%N/AN/AN/AN/A
SNOA
SONOMA PHARMACEUTICALS INC
$2.58MN/A0.00%N/AN/AN/AN/A
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
$16.18BN/A0.00%$0.0720N/AN/A3
AMRX
AMNEAL PHARMACEUTICALS INC
$1.88BN/A0.00%N/AN/AN/AN/A
ALVO
ALVOTECH
$3.38BN/A0.00%N/AN/AN/AN/A
SHPH
SHUTTLE PHARMACEUTICALS HOLDINGS INC
$7.05MN/A0.00%N/AN/AN/AN/A
HUGE
FSD PHARMA INC
$27.94MN/A0.00%N/AN/AN/AN/A
CYTH
CYCLO THERAPEUTICS INC
$40.20MN/A0.00%N/AN/AN/AN/A
IXHL
INCANNEX HEALTHCARE INC
$50.79MN/A0.00%N/AN/AN/AN/A
ALIM
ALIMERA SCIENCES INC
$204.18MN/A0.00%N/AN/AN/AN/A
BHC
BAUSCH HEALTH COMPANIES INC
$3.83BN/A0.00%N/AN/AN/AN/A
ELAN
ELANCO ANIMAL HEALTH INC
$7.97BN/A0.00%N/AN/AN/AN/A
EVO
EVOTEC SE
$2.77BN/AN/AN/AN/AN/AN/A
CTLT
CATALENT INC
$10.21BN/A0.00%N/AN/AN/AN/A
PBH
PRESTIGE CONSUMER HEALTHCARE INC
$3.61BN/A0.00%$0.4750N/AN/A0
LSDI
LUCY SCIENTIFIC DISCOVERY INC
$2.35MN/A0.00%N/AN/AN/AN/A
BGXX
BRIGHT GREEN CORP
$47.26MN/A0.00%N/AN/AN/AN/A

Pharmaceutical Stocks FAQ

What are the best pharmaceutical stocks to buy right now in Mar 2024?

According to Zen Score, the 3 best pharma stocks to buy right now are:

1. Neurocrine Biosciences (NASDAQ:NBIX)


Neurocrine Biosciences (NASDAQ:NBIX) is the top pharmaceutical stock with a Zen Score of 67, which is 41 points higher than the pharmaceutical industry average of 26. It passed 22 out of 33 due diligence checks and has strong fundamentals. Neurocrine Biosciences has seen its stock return 42.02% over the past year, overperforming other pharmaceutical stocks by 41 percentage points.

Neurocrine Biosciences has an average 1 year price target of $141.80, an upside of 2.88% from Neurocrine Biosciences's current stock price of $137.83.

Neurocrine Biosciences stock has a consensus Buy recommendation according to Wall Street analysts. Of the 15 analysts covering Neurocrine Biosciences, 40% have issued a Strong Buy rating, 20% have issued a Buy, 40% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Kamada (NASDAQ:KMDA)


Kamada (NASDAQ:KMDA) is the second best pharmaceutical stock with a Zen Score of 61, which is 35 points higher than the pharmaceutical industry average of 26. It passed 19 out of 33 due diligence checks and has strong fundamentals. Kamada has seen its stock return 21.74% over the past year, overperforming other pharmaceutical stocks by 21 percentage points.

Kamada has an average 1 year price target of $11.00, an upside of 96.43% from Kamada's current stock price of $5.60.

Kamada stock has a consensus Buy recommendation according to Wall Street analysts. Of the 1 analyst covering Kamada, 0% have issued a Strong Buy rating, 100% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Pacira Biosciences (NASDAQ:PCRX)


Pacira Biosciences (NASDAQ:PCRX) is the third best pharmaceutical stock with a Zen Score of 57, which is 31 points higher than the pharmaceutical industry average of 26. It passed 18 out of 33 due diligence checks and has strong fundamentals. Pacira Biosciences has seen its stock lose -27.53% over the past year, underperforming other pharmaceutical stocks by -29 percentage points.

Pacira Biosciences has an average 1 year price target of $48.75, an upside of 67.87% from Pacira Biosciences's current stock price of $29.04.

Pacira Biosciences stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 8 analysts covering Pacira Biosciences, 37.5% have issued a Strong Buy rating, 62.5% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the pharmaceutical stocks with highest dividends?

Out of 8 pharmaceutical stocks that have issued dividends in the past year, the 3 pharmaceutical stocks with the highest dividend yields are:

1. Siga Technologies (NASDAQ:SIGA)


Siga Technologies (NASDAQ:SIGA) has an annual dividend yield of 12.35%, which is 9 percentage points higher than the pharmaceutical industry average of 3.53%.

Siga Technologies's dividend payout ratio of 47.4% indicates that its high dividend yield is sustainable for the long-term.

2. Alkermes (NASDAQ:ALKS)


Alkermes (NASDAQ:ALKS) has an annual dividend yield of 3.93%, which is the same as the pharmaceutical industry average of 3.53%.

Alkermes's dividend payout ratio of 50% indicates that its dividend yield is sustainable for the long-term.

3. Phibro Animal Health (NASDAQ:PAHC)


Phibro Animal Health (NASDAQ:PAHC) has an annual dividend yield of 3.68%, which is the same as the pharmaceutical industry average of 3.53%. Phibro Animal Health's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Phibro Animal Health's dividend has shown consistent growth over the last 10 years.

Phibro Animal Health's dividend payout ratio of 129.7% indicates that its dividend yield might not be sustainable for the long-term.

Why are pharmaceutical stocks up?

Pharmaceutical stocks were up 1.19% in the last day, and up 0.68% over the last week.

We couldn't find a catalyst for why pharmaceutical stocks are up.

What are the most undervalued pharmaceutical stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued pharmaceutical stocks right now are:

1. Pacira Biosciences (NASDAQ:PCRX)


Pacira Biosciences (NASDAQ:PCRX) is the most undervalued pharmaceutical stock based on WallStreetZen's Valuation Score. Pacira Biosciences has a valuation score of 86, which is 68 points higher than the pharmaceutical industry average of 18. It passed 6 out of 7 valuation due diligence checks.

Pacira Biosciences's stock has dropped -27.53% in the past year. It has underperformed other stocks in the pharmaceutical industry by -29 percentage points.

2. Kamada (NASDAQ:KMDA)


Kamada (NASDAQ:KMDA) is the second most undervalued pharmaceutical stock based on WallStreetZen's Valuation Score. Kamada has a valuation score of 86, which is 68 points higher than the pharmaceutical industry average of 18. It passed 6 out of 7 valuation due diligence checks.

Kamada's stock has gained 21.74% in the past year. It has overperformed other stocks in the pharmaceutical industry by 21 percentage points.

3. Phibro Animal Health (NASDAQ:PAHC)


Phibro Animal Health (NASDAQ:PAHC) is the third most undervalued pharmaceutical stock based on WallStreetZen's Valuation Score. Phibro Animal Health has a valuation score of 71, which is 53 points higher than the pharmaceutical industry average of 18. It passed 5 out of 7 valuation due diligence checks.

Phibro Animal Health's stock has dropped -11.99% in the past year. It has underperformed other stocks in the pharmaceutical industry by -13 percentage points.

Are pharmaceutical stocks a good buy now?

61.7% of pharmaceutical stocks rated by analysts are a strong buy right now. On average, analysts expect pharmaceutical stocks to rise by 29.93% over the next year.

What is the average p/e ratio of the drug manufacturers - specialty & generic industry?

The average P/E ratio of the drug manufacturers - specialty & generic industry is 53.92x.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.